Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gérald Luc is active.

Publication


Featured researches published by Gérald Luc.


Metabolism-clinical and Experimental | 2013

Normal HDL-apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy

Paola Toledo-Ibelles; Martha Franco; Elizabeth Carreón-Torres; Gérald Luc; Anne Tailleux; Gilberto Vargas-Alarcón; José Manuel Fragoso; Carlos A. Aguilar-Salinas; María Luna-Luna; Oscar Pérez-Méndez

OBJECTIVEnThe kidney has been proposed to play a central role in apo AI catabolism, suggesting that HDL structure is determined, at least in part, by this organ. Here, we aimed at determining the effects of a renal mass reduction on HDL size distribution, lipid content, and apo AI turnover.nnnMETHODSnWe characterized HDL subclasses in rabbits with a 75% reduction of functional renal mass (Nptx group), using enzymatic staining of samples separated on polyacrylamide electrophoresis gels, and also performed kinetic studies using radiolabeled HDL-apo AI in this animal model.nnnRESULTSnCreatinine clearance was reduced to 35% after nephrectomy as compared to the basal values, but without increased proteinuria. A slight, but significant modification of the relative HDL size distribution was observed after nephrectomy, whereas cholesterol plasma concentrations gradually augmented from large HDL2b (+54%) to small HDL3b particles (+150%, P<0.05). Cholesteryl esters were the increased fraction; in contrast, free cholesterol phospholipids and triglycerides of HDL subclasses were not affected by nephrectomy. HDL-apo AI fractional catabolic rates were similar to controls.nnnCONCLUSIONnReduction of functional renal mass is associated to enrichment of HDL subclasses with cholesteryl esters. Structural abnormalities were not related to a low apo AI turnover, suggesting renal contribution to HDL remodeling beyond being just a catabolic site for these lipoproteins.


Anaesthesia, critical care & pain medicine | 2018

Epidemiology of out-of-hospital cardiac arrest: a French national incidence and mid-term survival rate study

Gérald Luc; Valentine Baert; Joséphine Escutnaire; Michael Genin; Christian Vilhelm; Christophe Di Pompeo; Carlos El Khoury; Nicolas Segal; Eric Wiel; Frédéric Adnet; Karim Tazarourte; Pierre-Yves Gueugniaud; Hervé Hubert; on behalf GR-RéAC

Out-of-hospital cardiac arrest (OHCA) is considered an important public health issue but its incidence has not been examined in France. The aim of this study is to define the incidence of OHCA in France and to compare this to other neighbouring countries. Data were extracted from the French OHCA registry. Only exhaustive centres during the period from January 1, 2013, to September 30, 2014 were included. All patients were included, regardless of their age and cause of OHCA. The participating centres covered about 10% of the French population. The study involved 6918 OHCA. The median age was 68 years, with 63% of males. Paediatric population (<15years) represented 1.8%. The global incidence of OHCA was 61.5 per 100,000 inhabitants per year in the total population corresponding to approximately 46,000 OHCA per year. In the adult population, we found an incidence of 75.3 cases per 100,000 inhabitants per year. In adults, the incidences were 100.3 and 52.7 in males and females, respectively. Most (75%) OHCA occurred at home and were due to medical causes (88%). Half of medical OHCA had cardiovascular causes. Survival rates at 30 days was 4.9% [4.4; 5.4] and increased to 10.4% [9.1; 11.7] when resuscitation was immediately performed by bystander at patients collapse. The incidence and survival at 30 days of OHCA in France appeared similar to that reported in other European countries. Compared to other causes of deaths in France, OHCA is one of the most frequent causes, regardless of the initial pathology.


European Journal of Cardiovascular Nursing | 2018

Age discrimination in out-of-hospital cardiac arrest care: a case-control study:

Eric Wiel; Christophe Di Pompeo; Nicolas Segal; Gérald Luc; Jean-Baptiste Marc; Carine Vanderstraeten; Carlos El Khoury; Joséphine Escutnaire; Karim Tazarourte; Pierre-Yves Gueugniaud; Hervé Hubert

Background: Although some studies have questioned whether cardiopulmonary resuscitation (CPR) in older people could be futile, age is not considered an essential out-of-hospital cardiac arrest (OHCA) prognostic factor. However, in the daily clinical practice of mobile medical teams (MMTs), age seems to be an important factor affecting OHCA care. Aims: The purpose of this study was to compare OHCA care and outcomes between young patients (<65 years old) and older patients. Methods: We performed a case-control study based on data extracted from the French National Cardiac Arrest (CA) registry. All adult patients with CA recorded between July 2011 and May 2014 were included. Each older patient was matched on three criteria: sex, initial cardiac rhythm and no-flow duration. Results: We studied 4347 pairs. We found significantly less basic life support initiation, shorter advanced cardiac life support duration, less MMT automated chest compression, less MMT ventilation and less MMT epinephrine injection in the older patients. Significant differences were also observed for return of spontaneous circulation (odds ratio (OR)=0.84, 95% confidence interval (CI) 0.77–0.92, p<0.001), transport to hospital (OR=0.58, 95% CI 0.51–0.61, p<0.001), vital status at hospital admission (OR=0.55, 95% CI 0.50–0.60, p<0.001) and vital status 30 days after CA (OR=0.42, 95% CI 0.35–0.50, p<0.001). Conclusion: All OHCA guidelines, ethical statements and clinical procedures do not propose age as a discrimination criterion in OHCA care. However, in our case-control study, we notice a shorter duration and less intensive care among older patients. This finding may partly explain the lower survival rate compared with younger people.


International Journal of Food Sciences and Nutrition | 2009

Small, qualitative changes in fatty acid intake decrease plasma low-density lipoprotein-cholesterol levels in mildly hypercholesterolemic outpatients on their usual high-fat diets

Jean-Michel Lecerf; Gérald Luc; Nadine Marécaux; Sylvie Bal; Jean-Paul Bonte; Brigitte Lacroix; Amélie Cayzeele

Objective The diet is the first step in managing hypercholesterolemia. The objective of the present study is to assess whether moderate changes in dietary fatty acids improve plasma lipid parameters in mildly hypercholesterolemic outpatients. Methods Using a randomized double-blind study, 121 outpatients within two groups received an isocaloric amount of unsaturated margarine or butter. Clinical and anthropometric measurements and a 3-day food record were made. Chi-square and Fishers tests were used to compare qualitative variables and the general linear procedure was used to compare the groups. Additional analyses were performed after adjustment. Results There was a significant difference (P <0.03) in low-density lipoprotein-cholesterol levels between the groups. Total cholesterol, low-density lipoprotein-cholesterol, non-high-density lipoprotein-cholesterol and apolipoprotein B values decreased in the unsaturated group in comparison with the saturated group. Low-density lipoprotein-cholesterol changes were correlated with the variation in polyunsaturated fatty acid intake and with plasma phospholipid linoleic acid levels. Conclusion A small change in saturated by polyunsaturated fatty acid intake may improve plasma lipid parameters in mildly hypercholesterolemic subjects.


Journal of Biological Chemistry | 2001

Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate.

Muriel Bouly; David Masson; Barbara Gross; Xian-Cheng Jiang; Catherine Fievet; Graciela Castro; Alan R. Tall; Jean-Charles Fruchart; Bart Staels; Laurent Lagrost; Gérald Luc


Post-Print | 2016

The very high cardiovascular risk in heterozygous familial ă hypercholesterolemia: Analysis of 734 French patients

Sophie Béliard; Aurélie Millier; Valérie Carreau; Alain Carrié; Philippe Moulin; Alexandre Fredenrich; Michel Farnier; Gérald Luc; David Rosenbaum; Mondher Toumi; E. Bruckert; French Fh Registry Grp


Archive | 2006

Triglycerides and Risk for Atherosclerotic Disease

Gérald Luc; Patrick Duriez; Jean-Charles Fruchart


Atherosclerosis Supplements | 2004

W11.280 Ciprofibrate increases synthesis and catabolism of HDL apo AI and AII in patients with hyperlipidemia

C. Huesca; Gérald Luc; N. Duhal; B. Lacroix; Jean-Charles Fruchart; Oscar Pérez-Méndez


Atherosclerosis Supplements | 2004

W11.276 Pioglitazone induces hypercatabolism of HDL-apolipoprotein A-I in the rabbit

E. Carréon; M. Juérez; Catherine Fievet; Gérald Luc; Oscar Pérez-Méndez


Atherosclerosis Supplements | 2001

Induction of the plasma phospholipid transfer protein (PLTP) gene accounts for the HDL enlargement in mice treated with fenofibrate. Lack of HDL size redistribution in treated PLTP-deficient mice

Muriel Bouly; David Masson; Barbara Gross; X.C. Jiang; Catherine Fievet; G. Castro; Alan R. Tall; Jean-Charles Fruchart; Bart Staels; Laurent Lagrost; Gérald Luc

Collaboration


Dive into the Gérald Luc's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge